on-01910 has been researched along with Lymphoma--B-Cell* in 1 studies
1 trial(s) available for on-01910 and Lymphoma--B-Cell
| Article | Year |
|---|---|
Phase I study of ON 01910.Na (Rigosertib), a multikinase PI3K inhibitor in relapsed/refractory B-cell malignancies.
Topics: Aged; Antineoplastic Agents; Enzyme Inhibitors; Female; Glycine; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell; Male; Middle Aged; Phosphoinositide-3 Kinase Inhibitors; Recurrence; Sulfones; Treatment Outcome | 2013 |